Usv Private Limited

Health Science Funding, LLC

Kamlesh Digambar Sawant

Dhananjay Govind Sathe

Tushar Anil Naik

Venkatasubramanian Radhakrishnan Tarur

Harish Kashinath Mondkar

Umesh Parashram Aher

Laxmikant Narhari Patkar

Gautam Ramjibhai Patel

Subhash Vishwanath Damle

Manoj Madhukarrao Deshpande

Parag Sukumar Gatne

V R Tarur

Harish Kashniath Mondkar

Narayana Rao Mantripragada

Avinash Venkataraman Naidu

The present invention relates to a process for preparation of Regadenoson and polymorphs thereof. In particular, the present invention relates to a process for preparation of Regadenoson Form C.

Process for preparation of regadenoson and polymorphs thereof

The present invention relates to an improved process for the preparation of Rasagiline or pharmaceutically acceptable salts thereof. The present invention also relates to Rasagiline salts, polymorphs thereof and process for preparation thereof.

Process for preparation of Rasagiline and salts thereof

Novel crystalline forms of anticompound (2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone) commonly known as Atovaquone and methods for producing the same is disclosed herein. This also provides pharmaceutical compositions comprising the said polymorphs of Atovaquone and method of treatingpneumonia, the method comprising administering to a warm blooded animal an effective amount of a product-by-process composition of matter comprising polymorphic forms of Atovaquone.

Polymorphs of atovaquone and process of preparation thereof

The present invention discloses a rapid resolution process of racemic clopidogrel base followed by conversion of the resolved (S) isomer to crystalline Clopidogrel bisulfate Form I. The invention also discloses novel racemization process of the unwanted (R) isomer of clopidogrel base. The invention further discloses an improved process for preparation of acid addition salts of clopidogrel.

Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I

The present invention discloses a novel, stable polymorph of 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride commonly known as Donepezil hydrochloride. Further the present invention discloses a process for producing Donepezil HCl amorphous and its polymorph Form (VI).

Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof

Growing community of inventors

Mumbai, India

Kamlesh Digambar Sawant